In August 2017, Veritas Genetics, the genome company acquired Curoverse, the computing and bioinformatics company behind the Personal Genome Project (PGP) at Harvard Medical School, and creator of the open-source platform Arvados - which firm had spun out of the work of geneticist George Church at Harvard and MIT. The press described the acquisition at the time as an effort to deploy large-scale artificial Iintelligence and machine learning in genomics. Curoverse software had already been in use by industry leaders such as the Wellcome Trust Sanger Institute to manage, process and share petabytes of genomic and biomedical data as well as facilitate AI and machine learning. The acquisition expanded the existing relationship between the two firms and enable the company to increase the production capacity and data management infrastructure. Curoverse, Inc. is an open source platform for handling massive amounts of genomic data for the medical and research industries. Built around the databases resulting from the Personal Genome Project, Arvados uses this data to link various elements of the known genomic data with information gathered in medical and other potential applications. As the amount of data available continues to grow, Curoverse's software will allow meaninful interaction and analysis. C
